Alignment Healthcare (NASDAQ:ALHC) Insider Sells $484,669.35 in Stock

Key Points

• Insider Robert Scavo sold 29,535 shares of Alignment Healthcare for approximately $484,669.35, reducing his ownership by 4.91%.
• Alignment Healthcare's stock has shown volatility, with a 12-month low of $8.82 and a high of $21.06, while trading at $16.45 recently.
• In its latest earnings report, Alignment Healthcare saw a 49% year-over-year increase in revenue and beat earnings estimates, reporting $1.02 billion in revenue.

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) insider Robert Scavo sold 29,535 shares of the firm's stock in a transaction dated Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total value of $484,669.35. Following the transaction, the insider directly owned 572,555 shares in the company, valued at approximately $9,395,627.55. This represents a 4.91% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Alignment Healthcare Stock Performance

NASDAQ ALHC traded down $0.03 on Wednesday, reaching $16.45. 4,860,124 shares of the company's stock traded hands, compared to its average volume of 2,946,361. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 2.29. Alignment Healthcare, Inc. has a 12 month low of $8.82 and a 12 month high of $21.06. The stock has a 50-day simple moving average of $14.27 and a 200 day simple moving average of $15.47.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.07) by $0.14. The company had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $960.25 million. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The firm's revenue was up 49.0% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.13) EPS. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, research analysts anticipate that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in ALHC. State of Wyoming lifted its position in shares of Alignment Healthcare by 133.9% in the 2nd quarter. State of Wyoming now owns 20,406 shares of the company's stock worth $286,000 after purchasing an additional 11,683 shares during the period. Caxton Associates LLP purchased a new stake in Alignment Healthcare in the second quarter worth about $240,000. Tower Research Capital LLC TRC lifted its holdings in Alignment Healthcare by 2,098.8% in the second quarter. Tower Research Capital LLC TRC now owns 19,679 shares of the company's stock worth $276,000 after buying an additional 18,784 shares during the period. Tidal Investments LLC boosted its position in Alignment Healthcare by 4.9% during the 2nd quarter. Tidal Investments LLC now owns 18,094 shares of the company's stock valued at $253,000 after acquiring an additional 852 shares in the last quarter. Finally, Gilder Gagnon Howe & Co. LLC purchased a new position in shares of Alignment Healthcare during the 2nd quarter worth approximately $2,039,000. 86.19% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

ALHC has been the subject of a number of recent research reports. Stephens raised Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Zacks Research raised Alignment Healthcare to a "hold" rating in a research note on Friday, August 8th. KeyCorp raised shares of Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 target price on the stock in a research note on Monday, August 25th. Wall Street Zen cut shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a research report on Sunday, August 10th. Finally, Barclays raised shares of Alignment Healthcare from an "underweight" rating to an "equal weight" rating and raised their price target for the stock from $9.00 to $13.00 in a report on Thursday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have issued a Hold rating to the company's stock. According to data from MarketBeat, Alignment Healthcare has an average rating of "Moderate Buy" and a consensus price target of $18.83.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.